Publicaciones en las que colabora con PABLO DEMELO RODRÍGUEZ (20)

2024

  1. Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort

    Viruses, Vol. 16, Núm. 3

2023

  1. Visceral extra-abdominal panniculitis after COVID19

    International Journal of Rheumatic Diseases, Vol. 26, Núm. 4, pp. 793-796

2022

  1. Arterial and venous involvement in Behçet’s syndrome: a narrative review

    Journal of Thrombosis and Thrombolysis, Vol. 54, Núm. 1, pp. 162-171

  2. Evaluation of simple laboratory parameters in SARS-CoV-2 infection: the role of ratios

    Infectious Diseases, Vol. 54, Núm. 12, pp. 924-933

  3. Undertreatment or Overtreatment With Statins: Where Are We?

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-14

  2. Long-term follow-up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding

    European Journal of Haematology, Vol. 106, Núm. 5, pp. 716-723

2020

  1. Accidente isquémico transitorio tras espaciar la dosis de alirocumab: ¿es recomendable reducir las dosis de iPCSK9 ante c-LDL muy bajos?

    Clínica e investigación en arteriosclerosis, Vol. 32, Núm. 1, pp. 30-32

  2. C-reactive protein level predicts 30-day mortality and bleeding in patients with venous thromboembolism: A prospective single-center study

    Medicina Clinica, Vol. 155, Núm. 2, pp. 51-56

  3. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels

    Thrombosis Research, Vol. 192, pp. 23-26

  4. Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1312-1320

  5. Niemann-Pick disease type-B: A unique case report with compound heterozygosity and complicated lipid management

    BMC Medical Genetics, Vol. 21, Núm. 1

  6. Transient ischaemic attack after spacing the dose of alirocumab: Is it advisable to reduce the doses of PCSK9 inhibitors with very low LDL-cholesterols?

    Clinica e Investigacion en Arteriosclerosis, Vol. 32, Núm. 1, pp. 30-32

2019

  1. Rivaroxaban for the treatment of venous thromboembolism in real life: A single-center prospective study

    Medicine, Vol. 98, Núm. 3, pp. e14093

  2. The efficacy of local liposomal bupivacaine infiltration on pain and recovery after Total Joint Arthroplasty

    Medicine (United States), Vol. 98, Núm. 3

  3. The fluid aspect of the mediterranean diet in the prevention and management of cardiovascular disease and diabetes: The role of polyphenol content in moderate consumption of wine and olive oil

    Nutrients, Vol. 11, Núm. 11

2018

  1. Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon

    Intractable and Rare Diseases Research, Vol. 7, Núm. 1, pp. 54-57

  2. Update on extended treatment for venous thromboembolism

    Annals of Medicine, Vol. 50, Núm. 8, pp. 666-674

  3. Usefulness of compounds with monacolin K in a case of statins intolerance

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 6, pp. 268-270

2016

  1. Bacteriemia por Actinomyces odontolyticus

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 0, Núm. 1, pp. 20-22